A 32-Week Randomized Comparison of Stepwise Insulin Intensification of Biphasic Insulin Aspart (BIAsp 30) Versus Basal–Bolus Therapy in Insulin-Naïve Patients with Type 2 Diabetes Sultan LinjawiByung-Wan LeeSalahedeen Abusnana Original Research Open access 11 November 2017 Pages: 1 - 11
The Cost-effectiveness of Dulaglutide 1.5mg versus Exenatide QW for the Treatment of Patients with Type 2 Diabetes Mellitus in France Mickael BassonDionysios NtaisKirsi Norrbacka Original Research Open access 13 November 2017 Pages: 13 - 25
Factors that may Account for Cardiovascular Risk Reduction with a Dipeptidyl Peptidase-4 Inhibitor, Vildagliptin, in Young Patients with Type 2 Diabetes Mellitus Marc EvansPlamen KozlovskiAngelo Avogaro Original Research Open access 13 November 2017 Pages: 27 - 36
Intravenous Ferric Carboxymaltose in Patients with Type 2 Diabetes Mellitus and Iron Deficiency: CLEVER Trial Study Design and Protocol Christoph SchindlerAndreas L. BirkenfeldStefan R. Bornstein Original Research Open access 13 November 2017 Pages: 37 - 47
Ertugliflozin in Patients with Stage 3 Chronic Kidney Disease and Type 2 Diabetes Mellitus: The VERTIS RENAL Randomized Study George GrunbergerSarah CampBrett Lauring Original Research Open access 20 November 2017 Pages: 49 - 66
In Vitro Inhibitory Activity of Acca sellowiana Fruit Extract on End Products of Advanced Glycation Alethia MuñizAbraham H. GarciaDaphne E. González Original Research Open access 22 November 2017 Pages: 67 - 74
Skin Autofluorescence is a Noninvasive Surrogate Marker for Diabetic Microvascular Complications and Carotid Intima–Media Thickness in Japanese Patients with Type 2 Diabetes: A Cross-sectional Study Keiji Yoshioka Original Research Open access 24 November 2017 Pages: 75 - 85
Achieving Good Glycemic Control Early After Onset of Diabetes: A Cost-Effectiveness Analysis in Patients with Type 1 Diabetes in Sweden Johan JendleÅsa EricssonRichard F. Pollock Original Research Open access 04 December 2017 Pages: 87 - 99
Serum Antioxidant Parameters are Significantly Increased in Patients with Type 2 Diabetes Mellitus after Consumption of Chinese Propolis: A Randomized Controlled Trial Based on Fasting Serum Glucose Level Weina GaoLingling PuChangjiang Guo Original Research Open access 06 December 2017 Pages: 101 - 111
Peer Education Group Intervention to Reduce Psychological Insulin Resistance: A Pilot Mixed-Method Study in a Chinese Population Ka Yan OrBenjamin Hoi-Kei YipKam Pui Lee Original Research Open access 07 December 2017 Pages: 113 - 124
An Indirect Comparison of Changes in the Impact of Weight on Quality of Life Among Subjects with Type 2 Diabetes Treated with Antihyperglycemic Agents in Dual Therapy with Metformin Shana B. TrainaApril SleeJoris Diels Original Research Open access 13 December 2017 Pages: 125 - 140
DPP-4 Inhibitor-Induced Rheumatoid Arthritis Among Diabetics: A Nested Case–Control Study Niranjan KatheAnuj ShahJacob T. Painter Original Research Open access 13 December 2017 Pages: 141 - 151
Hospital Admissions due to Dysglycaemia and Prescriptions of Antidiabetic Medications in England and Wales: An Ecological Study Abdallah Y. NaserQian WangLi Wei Original Research Open access 19 December 2017 Pages: 153 - 163
Rationale and Design for the J-DISCOVER Study: DISCOVERing the Treatment Reality of Type 2 Diabetes in a Real-World Setting in Japan—A Protocol Naoto KatakamiTomoya Mitaon behalf of the J-DISCOVER study group Original Research Open access 19 December 2017 Pages: 165 - 175
Ethnic Differences in Efficacy and Safety of Alogliptin: A Systematic Review and Meta-Analysis Yuli CaiTianshu ZengLulu Chen Original Research Open access 20 December 2017 Pages: 177 - 191
Ertugliflozin Compared with Glimepiride in Patients with Type 2 Diabetes Mellitus Inadequately Controlled on Metformin: The VERTIS SU Randomized Study Priscilla HollanderJie LiuBrett Lauring Original Research Open access 27 December 2017 Pages: 193 - 207
HbA1c is Positively Associated with Serum Carcinoembryonic Antigen (CEA) in Patients with Diabetes: A Cross-Sectional Study Jun LuHongtao WangXuemei Yu Original Research Open access 04 January 2018 Pages: 209 - 217
Assessing the Effect of Piperacillin/Tazobactam on Hematological Parameters in Patients Admitted with Moderate or Severe Foot Infections Will FrySean McCaffertyKetan K. Dhatariya Original Research Open access 04 January 2018 Pages: 219 - 228
A Class Comparison of Medication Persistence in People with Type 2 Diabetes: A Retrospective Observational Study Andrew McGovernWilliam HintonSimon de Lusignan Original Research Open access 04 January 2018 Pages: 229 - 242
Utility and Limitations of Glycated Hemoglobin (HbA1c) in Patients with Liver Cirrhosis as Compared with Oral Glucose Tolerance Test for Diagnosis of Diabetes Tejasav SehrawatAnuraag JindalYashdeep Gupta Original Research Open access 05 January 2018 Pages: 243 - 251
Ertugliflozin and Sitagliptin Co-initiation in Patients with Type 2 Diabetes: The VERTIS SITA Randomized Study Sam MillerTania KruminsBrett Lauring Original Research Open access 08 January 2018 Pages: 253 - 268
Glucose Control and Weight Change Associated with Treatment with Exenatide Compared with Basal Insulin: A Retrospective Study Christopher Ll. MorganQing QiaoCraig J. Currie Original Research Open access 09 January 2018 Pages: 269 - 283
Dapagliflozin and Empagliflozin Ameliorate Hepatic Dysfunction Among Chinese Subjects with Diabetes in Part Through Glycemic Improvement: A Single-Center, Retrospective, Observational Study Paul Chi Ho LeeYunjuan GuKaren Siu Ling Lam Original Research Open access 10 January 2018 Pages: 285 - 295
Patient Perceptions and Preferences for a Mealtime Insulin Delivery Patch Mark PeyrotDarlene DreonMeng H. Tan Original Research Open access 11 January 2018 Pages: 297 - 307
Characteristics of Elderly Patients Initiating Sitagliptin or Non-DPP-4-Inhibitor Oral Antihyperglycemic Agents: Analysis of a Cross-Sectional US Claims Database Tongtong WangAnn Marie McNeillSamuel S. Engel Original Research Open access 12 January 2018 Pages: 309 - 315
Evaluation of the Effect of Alogliptin on Tissue Characteristics of the Carotid Wall: Subanalysis of the SPEAD-A Trial Yoko IrieNaoto KatakamiStudy of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A) Collaborators Original Research Open access 12 January 2018 Pages: 317 - 329
Serum Bilirubin Concentration is Associated with Left Ventricular Remodeling in Patients with Type 2 Diabetes Mellitus: A Cohort Study Tomoaki InoueNoriyuki SonodaToyoshi Inoguchi Original Research Open access 15 January 2018 Pages: 331 - 338
Rapid-acting and Regular Insulin are Equal for High Fat-Protein Meal in Individuals with Type 1 Diabetes Treated with Multiple Daily Injections Karolina JabłońskaPiotr MolędaLilianna Majkowska Original Research Open access 17 January 2018 Pages: 339 - 348
A Review of Insulin Resistance in Type 1 Diabetes: Is There a Place for Adjunctive Metformin? Gagan PriyaSanjay Kalra Review Open access 14 November 2017 Pages: 349 - 361
Liraglutide Improves Cardiovascular Risk as an Add-on to Metformin and Not to Insulin Secretagogues in Type 2 Diabetic Patients: A Real-life 48-Month Retrospective Study Alessandro CiresiEnrica VigneriCarla Giordano Brief Report Open access 14 November 2017 Pages: 363 - 371
iGlarLixi Reduces Glycated Hemoglobin to a Greater Extent Than Basal Insulin Regardless of Levels at Screening: Post Hoc Analysis of LixiLan-L Elisabeth NiemoellerElisabeth SouhamiKlaus H. Jensen Brief Report Open access 16 November 2017 Pages: 373 - 382
Subgroup Analysis Stratified by Baseline Pancreatic β-cell Function in a Japanese Study of Dulaglutide in Patients with Type 2 Diabetes Noriyuki IwamotoAkiko MatsuiTomonori Oura Brief Report Open access 20 December 2017 Pages: 383 - 394
Individuals with Type 1 and Type 2 Diabetes Mellitus Trade Increased Hyperglycemia for Decreased Hypoglycemia When Glycemic Variability is not Improved Sujit R. JangamGary HayterTimothy C. Dunn Brief Report Open access 21 November 2017 Pages: 395 - 402
Effects of Ipragliflozin on Postprandial Glucose Metabolism and Gut Peptides in Type 2 Diabetes: A Pilot Study Hiroaki UenoHiroko NakazatoMasamitsu Nakazato Brief Report Open access 10 January 2018 Pages: 403 - 411
A Case of Maturity Onset Diabetes of the Young (MODY3) in a Family with a Novel HNF1A Gene Mutation in Five Generations A. K. OvsyannikovaO. D. RymarM. I. Voevoda Case Report Open access 08 December 2017 Pages: 413 - 420
Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitor as an Add-on Drug to GLP-1 Receptor Agonists for Glycemic Control of a Patient with Prader–Willi Syndrome: A Case Report Yukio HorikawaMayumi EnyaJun Takeda Case Report Open access 15 January 2018 Pages: 421 - 426
SGLT1 and SGLT1 Inhibitors: A Role to Be Assessed in the Current Clinical Practice Leonardo SpatolaSilvia FinazziSalvatore Badalamenti Commentary Open access 24 November 2017 Pages: 427 - 430
The Role of Glycemic Control and Variability in Diabetic Retinopathy Irini P. Chatziralli Commentary Open access 30 November 2017 Pages: 431 - 434
Early Clinical Expressions of Insulin Resistance: The Real Enemy to Look For René Rodríguez-GutiérrezAlejandro Salcido-MontenegroJosé Gerardo González-González Commentary Open access 05 December 2017 Pages: 435 - 438
Author Correction: Hospital Admissions due to Dysglycaemia and Prescriptions of Antidiabetic Medications in England and Wales: An Ecological Study Abdallah Y. NaserQian WangLi Wei Author Correction Open access 04 January 2018 Pages: 439 - 439
